Literature DB >> 27752737

Statins in patients with sepsis and ARDS: is it over? No.

Peter S Kruger1,2, Marius Terblanche3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27752737     DOI: 10.1007/s00134-016-4564-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  14 in total

1.  Septic shock--evaluating another failed treatment.

Authors:  Richard P Wenzel; Michael B Edmond
Journal:  N Engl J Med       Date:  2012-05-22       Impact factor: 91.245

Review 2.  Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*.

Authors:  Elizabeth K Stevenson; Amanda R Rubenstein; Gregory T Radin; Renda Soylemez Wiener; Allan J Walkey
Journal:  Crit Care Med       Date:  2014-03       Impact factor: 7.598

Review 3.  The ten "diseases" that are not true diseases.

Authors:  Pieter O Depuydt; John P Kress; Jorge I F Salluh
Journal:  Intensive Care Med       Date:  2015-07-01       Impact factor: 17.440

Review 4.  The Fragility Index in Multicenter Randomized Controlled Critical Care Trials.

Authors:  Elliott E Ridgeon; Paul J Young; Rinaldo Bellomo; Marta Mucchetti; Rosalba Lembo; Giovanni Landoni
Journal:  Crit Care Med       Date:  2016-07       Impact factor: 7.598

5.  Continuation of statin therapy in patients with presumed infection: a randomized controlled trial.

Authors:  Peter S Kruger; Meg L Harward; Mark A Jones; Christopher J Joyce; Karam M Kostner; Michael S Roberts; Bala Venkatesh
Journal:  Am J Respir Crit Care Med       Date:  2010-10-19       Impact factor: 21.405

Review 6.  Statins and sepsis: multiple modifications at multiple levels.

Authors:  Marius Terblanche; Yaniv Almog; Robert S Rosenson; Terry S Smith; Daniel G Hackam
Journal:  Lancet Infect Dis       Date:  2007-05       Impact factor: 25.071

Review 7.  Are there any benefits from statin treatment for the septic patient?

Authors:  Peter S Kruger; Bala Venkatesh
Journal:  Curr Atheroscler Rep       Date:  2014-01       Impact factor: 5.113

Review 8.  Statin therapy in critically-ill patients with severe sepsis: a review and meta-analysis of randomized clinical trials.

Authors:  G Thomas; S Hraiech; A Loundou; J Truwit; P Kruger; D F Mcauley; L Papazian; A Roch
Journal:  Minerva Anestesiol       Date:  2015-02-18       Impact factor: 3.051

9.  Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial).

Authors:  Jaimin M Patel; Catherine Snaith; David R Thickett; Lucie Linhartova; Teresa Melody; Peter Hawkey; Anthony H Barnett; Alan Jones; Tan Hong; Matthew W Cooke; Gavin D Perkins; Fang Gao
Journal:  Crit Care       Date:  2012-12-11       Impact factor: 9.097

10.  Effect of statin therapy on mortality from infection and sepsis: a meta-analysis of randomized and observational studies.

Authors:  You-Dong Wan; Tong-Wen Sun; Quan-Cheng Kan; Fang-Xia Guan; Shu-Guang Zhang
Journal:  Crit Care       Date:  2014-04-11       Impact factor: 9.097

View more
  6 in total

Review 1.  Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials.

Authors:  Myura Nagendran; Daniel F McAuley; Peter S Kruger; Laurent Papazian; Jonathon D Truwit; John G Laffey; B Taylor Thompson; Mike Clarke; Anthony C Gordon
Journal:  Intensive Care Med       Date:  2016-12-21       Impact factor: 17.440

Review 2.  Adjunctive therapies during veno-venous extracorporeal membrane oxygenation.

Authors:  Federico Pappalardo; Andrea Montisci
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 3.  Update of Sepsis in the Intensive Care Unit.

Authors:  Kelly Roveran Genga; James A Russell
Journal:  J Innate Immun       Date:  2017-07-12       Impact factor: 7.349

4.  Preventive Effects of Carnosine on Lipopolysaccharide-induced Lung Injury.

Authors:  Ken-Ichiro Tanaka; Toshifumi Sugizaki; Yuki Kanda; Fumiya Tamura; Tomomi Niino; Masahiro Kawahara
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

Review 5.  "MATH+" Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale.

Authors:  Pierre Kory; Ginfranco Umberto Meduri; Jose Iglesias; Joseph Varon; Flavio Adsuara Cadegiani; Paul E Marik
Journal:  J Clin Med Res       Date:  2022-02-24

Review 6.  Pleiotropic Effects of Statins: New Therapeutic Approaches to Chronic, Recurrent Infection by Staphylococcus aureus.

Authors:  Melissa D Evans; Susan A McDowell
Journal:  Pharmaceutics       Date:  2021-11-30       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.